InMed Pharmaceuticals (INM) Cash from Investing Activities Growth (3y) (2023)
Powered by 
Analysis
InMed Pharmaceuticals (INM) Cash from Investing Activities Growth (3y) (2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Corning | 145.55 Bn | 143.04 Bn | 1.63 Bn | -7.75% |
| 2 | Ati | 28.35 Bn | 27.57 Bn | 309.80 Mn | - |
| 3 | Qnity Electronics | 26.32 Bn | 25.36 Bn | 666.00 Mn | - |
| 4 | International Flavors & Fragrances | 21.50 Bn | 20.93 Bn | 853.00 Mn | -30.39% |
| 5 | DuPont de Nemours | 17.42 Bn | 15.68 Bn | 639.00 Mn | -3.15% |
| 6 | Avery Dennison | 12.98 Bn | 12.75 Bn | 729.40 Mn | 16.90% |
| 7 | Solstice Advanced Materials | 10.02 Bn | 9.27 Bn | 370.00 Mn | - |
| 8 | Element Solutions | 8.75 Bn | 8.56 Bn | 334.00 Mn | 47.41% |
| 9 | Eastman Chemical | 7.83 Bn | 7.14 Bn | 560.00 Mn | 26.17% |
| 10 | InMed Pharmaceuticals | 5.30 Mn | 61,528.56 | - | - |